Suppr超能文献

组蛋白去乙酰化酶5不是p53靶基因,但其过表达可抑制肿瘤细胞生长并诱导凋亡。

Histone deacetylase 5 is not a p53 target gene, but its overexpression inhibits tumor cell growth and induces apoptosis.

作者信息

Huang Yuanhui, Tan Mingjia, Gosink Mark, Wang Kevin K W, Sun Yi

机构信息

Cancer Molecular Sciences, Pfizer Global Research and Development, Ann Arbor Laboratories, 2800 Plymouth Road, Ann Arbor, MI 48105, USA.

出版信息

Cancer Res. 2002 May 15;62(10):2913-22.

Abstract

p53 tumor suppressor is activated by phosphorylation and acetylation on DNA damage. One of unknown p53 early transcripts was identified to be histone deacetylase-5 (HDAC5). We tested a hypothesis that HDAC5 is a p53 down-stream target gene that on induction by p53 inactivates p53 by removal of acetyl group in p53 molecule, thus functioning as an auto-regulatory negative feedback loop in analogue to p53-murine double minute 2 interaction. Six p53 binding consensus sites were identified in the promoter of HDAC5. p53 binds to one of the sites weakly. However, luciferase constructs driven by the HDAC5 promoter containing three to six potential binding sites were not activated by p53, nor was the expression of HDAC5 mRNA induced by p53-activating agents. Furthermore, HDAC5 does not bind to p53 nor reduces etoposide-induced p53 acetylation. Thus, HDAC5 is not a p53 target gene and may act in a p53-independent manner. We next studied the effect of HDAC5 on tumor cell growth and apoptosis. Transfection of HDAC5 inhibited growth of multiple tumor cell lines including U2OS osteogenic sarcoma cells, SY5Y neuroblastoma cells, and MCF breast carcinoma cells. The growth suppression seen in HDAC5-overexpressing cells appears to be attributable partly to a reduced growth rate as revealed by cell growth assay using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay and mainly to spontaneous apoptosis as shown by DNA fragmentation ELISA and morphological appearance. Mechanistically, repression of three cell proliferation genes in mitogen-activated protein kinase pathway and induction of seven apoptosis-related genes were identified by microarray profiling in HDAC5-overexpressed cells. Among induced genes, four (TNFR1, TNFSF7, caspase-8, and DAPK1) were associated with the tumor necrosis factor ligand-receptor death pathway. Induction of TNFR1, TNFSF7, and caspase-8 were confirmed by Northern and Western analyses. Thus, activation of tumor necrosis factor death receptor pathway appears to be associated with HDAC5-induced spontaneous apoptosis.

摘要

p53肿瘤抑制因子在DNA损伤时通过磷酸化和乙酰化被激活。一个未知的p53早期转录本被鉴定为组蛋白去乙酰化酶5(HDAC5)。我们测试了一个假设,即HDAC5是p53的下游靶基因,其在被p53诱导后通过去除p53分子中的乙酰基来使p53失活,从而在类似于p53-鼠双微体2相互作用中发挥自动调节负反馈环的作用。在HDAC5启动子中鉴定出6个p53结合共有位点。p53与其中一个位点结合较弱。然而,由含有三到六个潜在结合位点的HDAC5启动子驱动的荧光素酶构建体未被p53激活,p53激活剂也未诱导HDAC5 mRNA的表达。此外,HDAC5不与p53结合,也不降低依托泊苷诱导的p53乙酰化。因此,HDAC5不是p53靶基因,可能以p53非依赖的方式发挥作用。接下来,我们研究了HDAC5对肿瘤细胞生长和凋亡的影响。HDAC5的转染抑制了多种肿瘤细胞系的生长,包括U2OS骨肉瘤细胞、SY5Y神经母细胞瘤细胞和MCF乳腺癌细胞。在HDAC5过表达细胞中观察到的生长抑制似乎部分归因于生长速率降低,这通过使用3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐试验的细胞生长测定揭示,主要归因于DNA片段化ELISA和形态学表现所示的自发凋亡。从机制上讲,通过在HDAC5过表达细胞中的微阵列分析,鉴定出有丝分裂原激活蛋白激酶途径中的三个细胞增殖基因受到抑制,七个凋亡相关基因被诱导。在诱导基因中,四个(TNFR1、TNFSF7、caspase-8和DAPK1)与肿瘤坏死因子配体-受体死亡途径相关。通过Northern和Western分析证实了TNFR1、TNFSF7和caspase-8的诱导。因此,肿瘤坏死因子死亡受体途径的激活似乎与HDAC5诱导的自发凋亡相关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验